Production (Stage)
VentriPoint Diagnostics Ltd.
VPTDF
$0.0919
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | 672.41% | -- | 46.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | 672.41% | -- | 46.86% |
| Cost of Revenue | -- | -- | -- | -- | -100.00% |
| Gross Profit | -100.00% | 1,046.00% | 672.41% | -- | 85.37% |
| SG&A Expenses | -22.03% | 25.94% | 16.28% | -12.36% | 38.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.32% | 4.28% | 22.84% | -14.74% | 12.13% |
| Operating Income | 17.66% | 1.06% | -20.60% | 14.50% | -11.26% |
| Income Before Tax | 10.19% | -4.77% | -24.95% | 11.31% | -11.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.75% | -4.77% | -24.95% | 11.31% | -11.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.75% | -4.77% | -24.95% | 11.31% | -11.76% |
| EBIT | 17.66% | 1.06% | -20.60% | 14.50% | -11.26% |
| EBITDA | 17.58% | 0.97% | -20.70% | 14.47% | -11.39% |
| EPS Basic | 18.97% | -3.57% | -24.53% | 11.11% | -11.54% |
| Normalized Basic EPS | 11.11% | -2.86% | -24.24% | 12.50% | -12.50% |
| EPS Diluted | 18.97% | -3.57% | -24.53% | 11.11% | -11.54% |
| Normalized Diluted EPS | 11.11% | -2.86% | -24.24% | 12.50% | -12.50% |
| Average Basic Shares Outstanding | 2.86% | 0.42% | 0.23% | 0.20% | 0.06% |
| Average Diluted Shares Outstanding | 2.86% | 0.42% | 0.23% | 0.20% | 0.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |